Mereo Biopharma Group Plc (MREO)

Last Three Months

22-Aug-24 -- 21-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

2

0

5

+1

0

+2

0

+3

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Sep-24 8:49 PM View:	13-Sep-24 Sale ($46.17K)	Lewicki John A. Chief Scientific Officer		Mereo Biopharma Group Plc - MREO	47% 62.98K to 92.83K	0	0	--	--	Show Txns Hide Txns

16-Sep-24 8:47 PM View:	13-Sep-24 Sale ($80.87K)	Fox Chrisitne Ann Chief Financial Officer		Mereo Biopharma Group Plc - MREO	55% 57.57K to 89.28K	0	0	--	--	Show Txns Hide Txns

23-Aug-24 6:13 PM View:	22-Aug-24 Option Sale ($466.21K)	Pakianathan Deepika Director		Mereo Biopharma Group Plc - MREO	0% --	0	0	--	--	Show Txns Hide Txns

16-Sep-24 8:46 PM View:	13-Sep-24 Sale ($423.42K)	Hughes-Wilson Alexandra See Remarks		Mereo Biopharma Group Plc - MREO	46% 34.55K to 50.48K	0	0	--	--	Show Txns Hide Txns

16-Sep-24 8:48 PM View:	13-Sep-24 Sale ($88.41K)	Sermon Charles General Counsel		Mereo Biopharma Group Plc - MREO	19% 184.39K to 219.06K	0	0	--	--	Show Txns Hide Txns

16-Sep-24 8:50 PM View:	13-Sep-24 Sale ($253.45K)	Pollard-Knight Denise Chief Executive Officer Director		Mereo Biopharma Group Plc - MREO	14% 709.52K to 808.92K	0	0	--	--	Show Txns Hide Txns